Akeso enrols first patient in phase Ia trial for AK146D1, a bispecific ADC targeting Trop2 and Nectin4: Hong Kong Monday, July 7, 2025, 18:00 Hrs [IST] Akeso, Inc., a leading biop ...

HONG KONG, July 3, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") has announced the successful ...

IDMC's formal review concluded that the therapy met the pre-defined superiority criteria, showing significant efficacy.

Drug candidate is one of several oncology assets approaching or in clinical development, discovered through Oxford ...

unveiling its forward-looking strategy centered on dual innovation in next-generation immuno-oncology (IO) and antibody-drug conjugate (ADC) technologies. This strategic focus aims to redefine the ...

Bio-Thera Solutions has initiated dosing in the randomised Phase III trial of the antibody-drug conjugate (ADC), BAT8006, ...

We are at an inflection point that is driving a renaissance in antibody-drug conjugate (ADC) development. As successes in the clinic have led to more U.S. Food & Drug Administration (FDA) approvals, ...

Developer IO Interactive is developing a co-op mode for Hitman: World of Assassination.

IO Interactive has officially unveiled '007 First Light', its long-gestating James Bond game – check out the reveal trailer here.

IO Interactive finally showed off its take on James Bond with a new trailer for 007 First Light at Sony's State of Play.